You have 9 free searches left this month | for more free features.

Biliary tract cancers

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Trace Element Deficiency Trial in Ljubljana (trace elements)

Recruiting
  • Trace Element Deficiency
  • trace elements
  • Ljubljana, Slovenia
    Institute of Oncology Ljubljana
Sep 27, 2023

Postoperative Recurrence in Biliary Tract Cancers:A Multicenter

Recruiting
  • Biliary Tract Cancer
  • No intervention
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with NanJing Medical University
Feb 15, 2023

Biliary Tract Cancers Trial (durvalumab)

Not yet recruiting
  • Biliary Tract Cancers
  • (no location specified)
Jun 20, 2023

Pancreatic Cancer Trial in Baltimore (Gemcitabine, Cisplatin, Pembrolizumab)

Not yet recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    SKCCC Johns Hopkins
Aug 16, 2023

Biliary Tract Carcinoma, Cholangiocarcinoma, Bile Duct Cancer Trial in Madison (Gemcitabine, Cisplatin, Zimberelimab)

Not yet recruiting
  • Biliary Tract Carcinoma
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin
Sep 15, 2023

Biliary Tract Cancer Trial in Montréal (Tumour and germline molecular profiling)

Recruiting
  • Biliary Tract Cancer
  • Tumour and germline molecular profiling
  • Montréal, Quebec, Canada
    McGill University Health Centre
Nov 2, 2022

Biliary Tract Cancer, Cholangiocarcinoma, Biliary Tract Tumors Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL))

Recruiting
  • Biliary Tract Cancer
  • +2 more
  • Tumor Infiltrating Lymphocytes (TIL)
  • Pittsburgh, Pennsylvania
    Allyson Welsch
Jul 21, 2022

Incidental Gallbladder Carcinoma-Permanent Platform Including

Recruiting
  • Biliary Tract Cancer
  • Neoadjuvant, Adjuvant and 1st Line
    • Frankfurt, Germany
      Krankenhaus Nordwest GmbH
    Aug 3, 2022

    Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer Trial (CTX-009, Paclitaxel)

    Not yet recruiting
    • Biliary Tract Cancer
    • +3 more
    • (no location specified)
    Aug 16, 2022

    Biliary Tract Tumors Trial (Envafolimab plus Gemcitabine&Cisplatin, Gemcitabine&Cisplatin)

    Not yet recruiting
    • Biliary Tract Neoplasms
    • (no location specified)
    Jun 8, 2022

    Cholangiocarcinoma, Stage III Gallbladder Cancer AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7 Trial in Scottsdale, Rochester

    Active, not recruiting
    • Cholangiocarcinoma
    • +6 more
    • Laboratory Biomarker Analysis
    • Trifluridine/Tipiracil Hydrochloride Combination Agent TAS-102
    • Scottsdale, Arizona
    • +1 more
    Jan 4, 2023

    Biliary Tract Cancer Trial in Philadelphia (XmAb20717)

    Recruiting
    • Biliary Tract Cancer
    • Philadelphia, Pennsylvania
      Abramson Cancer Center at University of Pennsylvania
    Apr 11, 2022

    Biliary Tract Cancer, Cholangiocarcinoma Trial in Italy (Gemcitabine, Nab paclitaxel, Cisplatin)

    Not yet recruiting
    • Biliary Tract Cancer
    • Cholangiocarcinoma
    • Ancona, Italy
    • +18 more
    Sep 16, 2023

    LIver, Biliary tRAct and pancReatic Cancers

    Recruiting
    • Liver Cancer
    • +2 more
    • Blood drawing
    • Hangzhou, Zhejiang, China
      The Second Affiliated Hospital, Zhejiang University School of Me
    Nov 14, 2023

    Advanced Biliary Tract Cancer Trial in United States (Durvalumab, Regorafenib)

    Recruiting
    • Advanced Biliary Tract Cancer
    • Overland Park, Kansas
    • +4 more
    May 17, 2022

    Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancers Trial (ABBV-400)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • +6 more
    • (no location specified)
    Oct 10, 2023

    Biliary Tract Cancer Trial in Riyadh (FOLFIRINOX)

    Recruiting
    • Biliary Tract Cancer
    • FOLFIRINOX
    • Riyadh, Saudi Arabia
      king Faisal Specialist Hospital and Research Center
    Aug 30, 2021

    Biliary Tract Cancer Trial in Worldwide (Durvalumab, Gemcitabine monotherapy, Gemcitabine + cisplatin)

    Not yet recruiting
    • Biliary Tract Cancer
    • Durvalumab
    • +7 more
    • Orange, California
    • +36 more
    Mar 6, 2023

    Recurrent Biliary Tract Carcinoma, Recurrent Distal Bile Duct Adenocarcinoma, Recurrent Gallbladder Carcinoma Trial

    Not yet recruiting
    • Recurrent Biliary Tract Carcinoma
    • +13 more
    • (no location specified)
    Nov 8, 2022

    Biliary Tract Cancer Trial (Fresh tumor tissue biopsy, Blood draw, Archival tumor tissue collection)

    Withdrawn
    • Biliary Tract Cancer
    • Fresh tumor tissue biopsy
    • +2 more
    • (no location specified)
    Mar 30, 2021

    Advanced Bile Duct Carcinoma, Advanced Gallbladder Carcinoma, Refractory Bile Duct Carcinoma Trial in Rochester (Irinotecan,

    Active, not recruiting
    • Advanced Bile Duct Carcinoma
    • +17 more
    • Rochester, Minnesota
      Mayo Clinic
    Jan 5, 2023

    Unresectable Pancreatic Cancer, Unresectable Bile Duct Carcinoma, Unresectable Biliary Tract Carcinoma Trial (Tripegfilgrastim)

    Not yet recruiting
    • Unresectable Pancreatic Cancer
    • +2 more
    • (no location specified)
    Nov 13, 2023

    A Questionnaire Survey for Biliary Tract Cancers

    Enrolling by invitation
    • Biliary Tract Cancer
      • Daegu, Korea, Republic of
        Kyungpook National University Chilgok Hospital
      Jan 28, 2021

      Advanced Biliary Tract Cancer, Neuroendocrine Tumors, Female Reproductive System Tumor Trial in Australia (Ipilimumab,

      Recruiting
      • Advanced Biliary Tract Cancer
      • +3 more
      • Albury, New South Wales, Australia
      • +11 more
      Oct 31, 2022

      Gastric Cancer in Situ, Pancreatic Cancers, Biliary Cancers Trial in Taipei (Oxaliplatin, Albumin-Bound Paclitaxel

      Completed
      • Gastric Cancer in Situ
      • +2 more
      • Taipei, Taiwan
        Taiwan Cooperative Oncology Group, National Health Research Inst
      Apr 5, 2022